Table 3.
Histological Type | pT1-T2 Node Metastasis/Cases |
pT3-T4 Node Metastasis/Cases |
All Node Metastasis/Cases |
|
---|---|---|---|---|
Low risk | Acinic cell carcinoma | 0/13 | 2/3 (66.6%) | 2/16 (12.5%) |
Mucoepidermoid carcinoma (low grade) | 0/10 | 0/2 | 0/12 | |
Carcinoma ex pleomorphic adenoma | 0/6 | 1/2 (50%) | 1/2 (50%) | |
Oncocytic carcinoma | 1/1 (100%) | 1/2 (50%) | 2/3 (66.6%) | |
Myoepithelial carcinoma | 0/1 | 0/3 | 0/4 | |
Secretory carcinoma | 0/3 | - | 0/3 | |
TOTAL LOW RISK | 1/34 (2.9%) * | 4/12 (33%) * | 5/46 (10.9%) * | |
High risk | Adenocarcinoma | 1/1 (100%) | 0/1 | 1/8 (12.5%) |
Mucoepidermoid carcinoma (high grade) | - | 0/1 | 0/1 | |
Primitive squamous cell carcinoma | 1/2 (50%) | 0/1 | 1/3 (33.3%) | |
Adenoid cystic carcinoma | 0/2 | 1/6 (16.6%) | 1/8 (12.5%) | |
Salivary duct carcinoma | 1/2 (50%) | - | 1/2 (50%) | |
High-grade carcinoma NOS a | 0/1 | 1/1 (100%) | 1/2 (50%) | |
Undifferentiated carcinoma | 1/1 (100%) | - | 1/1 (100%) | |
TOTAL HIGH RISK | 4/9 (44.4%) | 2/10 (20%) | 6/19 (31.6%) * |
a NOS: not otherwise specified. * p < 0.05.